# A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia

> **NCT00483964** · PHASE2 · COMPLETED · sponsor: **Q.Mundewadi Ayurvedic Research & Charitable Trust** · enrollment: 200 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Bacopa monnieri
- **DRUG:** Nardostachys jatamansi
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00483964
- **Lead sponsor:** Q.Mundewadi Ayurvedic Research & Charitable Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2007-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483964, "A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00483964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*